Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

ClinicalTrials.gov ID: NCT02016885

Public ClinicalTrials.gov record NCT02016885. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 4:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Vehicle Controlled, Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of glycopyrrolate compared to vehicle for the treatment of axillary hyperhidrosis.

Study identification

NCT ID
NCT02016885
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Journey Medical Corporation
Industry
Enrollment
198 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2013 (Type not available)
Primary completion
Sep 2014 (Actual)
Completion
Sep 2014 (Actual)
Last update posted
Aug 25, 2021

2013 – 2014

United States locations

U.S. sites
21
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Burke Pharmaceutical Research Hot Springs Arkansas 71913 —
Gary M. Petrus, MD, PA Little Rock Arkansas 72202 —
California Dermatology & Clinical Research Institute Encinitas California 92024 —
Center For Dermatology Clinical Research Fremont California 94538 —
Florida Academic Dermatology Center Miami Florida 33136 —
Kenneth R. Beer, MD, PA West Palm Beach Florida 33401 —
Shideler Clinical Research Center Carmel Indiana 46032 —
Cypress Medical Research Center, LLC Wichita Kansas 67226 —
Minnesota Clinical Study Center Fridley Minnesota 55432 —
Saint Louis University Dermatology St Louis Missouri 63122 —
Skin Specialists, PC Omaha Nebraska 68144 —
The Dermatology Group, PC Verona New Jersey 07044 —
Oregon Medical Research Center Portland Oregon 97223 —
J&S Studies, Inc. College Station Texas 77845 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Dermatology Research Center, Inc. Salt Lake City Utah 84117 —
Virginia Clinical Research, Inc. Norfolk Virginia 23507 —
Westend Dermatology Associates Richmond Virginia 23233 —
Dermatology Associates Seattle Washington 98101 —
Women's Clinical Research Center Seattle Washington 98105 —
Premier Clinical Research Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02016885, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2021 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02016885 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →